The fact is, there are plenty of reasons to be proactive about discussing intimate changes in the body with a medical professional
The Biologics License Application is expected Q1 2027, with realistic approval between the second half of 2027 and mid-2028
The remaining TRIUMPH readouts, particularly TRIUMPH-1 in general obesity and TRIUMPH-3 in obesity + cardiovascular risk, will establish whether the 28% threshold holds across less-selected populations or whether it relaxes toward the 20-24% range Phase 2 established
MHRA Approved June 2026 Novo Nordisk Wegovy Tablets Once-daily oral semaglutide tablets the weight loss tablet that's changing everything Once-daily oral semaglutide tablet same active ingredient as the Wegovy injection, now in tablet form Clinically proven participants lost up to 16.6% of body weight after 64 weeks (OASIS 4 trial) Available in four tablet strengths: 1.5mg, 4mg, 9mg, and 25mg No needles, no sharps bin, no refrigeration required Made by Novo Nordisk the manufacturer of Wegovy injections and Ozempic MHRA-approved on 11 June 2026 available from 7th July 2026 Prescription-only medicine
And I can tell you this much: Most of what youre reading about the BPC-157 nasal spray online is either dangerously overhyped or completely wrong
Def recommend It is a multi-compound research blend supplied in a single vial, combining GHK-Cu (50 mg), KPV (10 mg), BPC-157 (10 mg) and TB-500 (10 mg)